Clinafloxacin (CI 960) is Superior to Standard Therapeutics in the Treatment of Murine Listeriosis and Salmonellosis
- 31 October 1997
- journal article
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 286 (3), 401-412
- https://doi.org/10.1016/s0934-8840(97)80099-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Efficacy of quinolones in preventing Staphylococcus aureus-induced abscess in miceJournal of Antimicrobial Chemotherapy, 1995
- Activity of CI -960 alone and in combination with amoxycillin against Listeria monocytogenes, and comparison with other quinolonesJournal of Antimicrobial Chemotherapy, 1995
- Antimicrobial chemotherapy of human infection due toListeria monocytogenesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococciAntimicrobial Agents and Chemotherapy, 1994
- Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cellsAntimicrobial Agents and Chemotherapy, 1994
- Comparative in vitro activities of new quinolones against coryneform bacteriaAntimicrobial Agents and Chemotherapy, 1994
- The fluoroquinolones - reappraisalInternational Journal of Antimicrobial Agents, 1992
- Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.The Journal of Experimental Medicine, 1992
- Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevanceClinical Microbiology Reviews, 1992
- Innate immunity to a facultative intracellular bacterial pathogenCurrent Opinion in Immunology, 1992